MRD / Regn No. : THBC\23-24\08992 Date : 08/07/2026
Patient Name : Sabyasachi Das Age & Gender : 46 Yrs. / Male
Contact No. : 9819199033 UHID :
Ht / Wt / BMI : 177.8 / 104.95 / 33.20 BP S / BP D : 152 / 81
Allergies : NONE Referred By :
   
Problem List : T2DM (03/Apr/2016) |
Subjective : T2DM SINCE 2016,NO F/H OF THYROID CANCER / NO PANCREATITIS,NO GALL BLADDER STONES,DISCUSSED STRENGTH TRAINING / WILL OPTIMISE PROTEIN
Objective : 06-JUL-2026 REPORTS,HB-14.2/ HBA1C-7.5%,FBS-158/ PPBS-162,ALT-56/ AST-36,TC-190/ TG-93/ LDL-136/ HDL-45,FT3-3.37/ T4-1.24/ TSH-1.830,LIPASE-21/ AMYLASE-48,JAN 2026 - GRADE 2 FATTY LIVER
Plan : STOP TRAJENTA WHEN YOU MOVE TO 5 MG  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TRAJENTA DUO (2.5/500) ORAL 1-0-1 ABF / AD
 30 DAYS
2 INJ MOUNJARO 2.5 MG SC 1/WEEK ANYTIME OF DAY
 1 MTH
3 INJ MOUNJARO 5 MG SC 1/WEEKLY ANYTIME
2 MTHS
       
Refill : 0 / Substitution:    
Education : IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.
Next Visit : 08/Oct/2026
Tests Suggested For Next Visit : FBS / PPBS / HBA1C / LFT > 3 MTHS,RETINA TEST FOR DIABETIC RETINOPATHY
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: